XNAS: RNAZ
TransCode Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Pha...
Read More
4.70
-0.65
(-12.15%)
31,649
XNAS Volume
XNAS 18 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
TransCode Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..